About
Sam Ruta leads commercial strategy at DirectSeq, focusing on market growth and client engagement for RNA therapeutic solutions. With a background in biotech business development, Sam has driven partnerships that positioned DirectSeq as a leader in molecular analytics for RNA therapeutics.
As a forward-thinking executive with over two decades of dynamic experience in the healthcare space . I bring a proven track record in sales and business development. My creative and highly technical sales mindset fuels a passion for sales and overall organizational success. The end result is red carpet service for Physicians and patient care. Recognized for assembling high-performing teams, I lead them to surpass sales and business growth targets consistently.
Key Strengths: 🚀 Strategic Vision: Known for identifying and capitalizing on emerging trends within the sales process. 🌐 Relationship Mastery: Cultivating strong client relationships is at the core of my approach. I specialize in understanding unique client needs and delivering tailored solutions, resulting in heightened satisfaction and exceptional client retention. 📈 Business Expansion: Adept at uncovering new business prospects, forging strategic partnerships, and identifying revenue streams through vigilant market trend analysis and competitor monitoring.
Notable Achievements: 💡 Innovative Growth: Spearheaded the expansion into Pharmacogenetic (PGx), Cancer Genetic (CGx), and Next-Generation Sequencing (NGS) testing areas, diversifying Alliance Dx -Tesis service offerings and securing $30 million in new client revenue. 🌐 Network Expansion: Successfully obtained commitments from 100 new physicians in the GI-GU-and Hematology/Oncology space resulting in a new 40m dollar run rate. 🤝 Strategic Collaboration: Orchestrated the creation of GenPath and Pathline in collaboration with Bioreference labs and Orange Pathology Associates.